Written answer
Medical Aids and Appliances
1007. Deputy David Cullinane asked the Minister for Health whether the HSE is discontinuing toshai blister packs or removing associated machines from pharmacies; the reasons, timeline, and consultation undertaken; whether changes will be paused pending assessment of patient safety and accessibility; the alternatives for patients unable to use standard blister packs; the supports for blister-packing costs, including for long-term illness scheme patients; and if she will make a statement on the matter. [79661/26]
Comment on this
My Department has not placed any requirements on operational aspects for blister-packing practices in community pharmacies, nor does it specify any particular automation aspects.
Regarding supports for blister-packing costs, in March 2026 I announced the introduction of a new patient-centred medicines optimisation support service (MOSS) framework which commenced on 1 June 2026.
This framework is designed to strengthen supports for medical card holders in vulnerable patient groups, including those with diagnosed cognitive impairment or dementia, intellectual disability, physical impairment or those patients at risk of medication misuse. The reform ensures that resources are targeted towards those who genuinely need them. These patients will be supported where appropriate with a range of tailored supports including:
• adjustments to facilitate use of original packaging.
• medication reminder systems.
• administration charts.
• instalment dispensing; and
• blister packs where clinically necessary.
Blister packs remain a last resort in line with the international evidence due to associated risks including reduced patient autonomy and potential safety concerns. It is also important to note that not all medicines are suitable for blister packs. Pharmacists will consider relevant medicine-specific factors to assess if all the patient’s individual medicines are suitable for supply in a blister pack. Where clinically required, and deemed appropriate, blister packs will be provided free-of-charge to eligible medical card patients, in identified cohorts.
Importantly, medical card patients, who were receiving blister packs free-of-charge prior to the Community Pharmacy Agreement (in August 2025) will continue to do so.
If a patient does not have a medical card, their pharmacist will be able to advise them on the supports that are available and the associated cost. Pharmacies are independent businesses and accordingly, may set the price for the privately-funded services they provide. As a result, prices for professional services may vary from pharmacy to pharmacy. All pharmacies are required to provide clear and accessible pricing information to the public, in accordance with www.psi.ie/practice-supports/guidance-and-guidelines-pharmacists-and-pharmacies/guidance-support-price-transparency.
Regarding patients with eligibility under the Long Term Illness (LTI) Scheme, the MOSS supports apply only to patients with medical cards, not to those solely with LTI eligibility. However, if a patient needs help in managing their medicines, their pharmacist will be able to advise them about the risks and benefits of different supports, and any associated costs, in order to determine the most appropriate one for them.